Gordon KB, Langley RG, Warren RB, Okubo Y, et al. Bimekizumab safety in patients with moderate to severe plaque psoriasis: Pooled data from up to three years of treatment in randomized phase 3 trials. Br J Dermatol 2023 Nov 10:ljad429. doi: 10.1093.
PMID: 37950894